Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$783M |
| 2 |
Danaher
DHR
|
+$423M |
| 3 |
Prologis
PLD
|
+$411M |
| 4 |
Apple
AAPL
|
+$388M |
| 5 |
Amazon
AMZN
|
+$325M |
Top Sells
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$505M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
NL Industries
NL
$298M
| $971K | ﹤0.01% |
142,698
+1,948
| +1% | +$13.3K |
|
3352
Akebia Therapeutics
AKBA
$777M
| $970K | ﹤0.01% |
1,682,498
+60,673
| +4% | +$35K |
|
|
TCN
3353
DELISTED
Tricon Residential Inc.
TCN
| $966K | ﹤0.01% |
125,377
+944
| +0.8% | +$7.27K |
|
3354
AEye
LIDR
$106M
| $965K | ﹤0.01% |
66,960
+22,150
| +49% | +$319K |
|
3355
CytomX Therapeutics
CTMX
$341M
| $964K | ﹤0.01% |
603,075
+15,624
| +3% | +$25K |
|
|
NBIS
3356
Nebius Group N.V. Class A Ordinary Shares
NBIS
$22.3B
| $961K | ﹤0.01% |
280,281
| – | – |
|
|
OPTN
3357
DELISTED
OptiNose
OPTN
| $960K | ﹤0.01% |
34,621
-69
| -0.2% | -$1.91K |
|
3358
First United
FUNC
$236M
| $958K | ﹤0.01% |
48,791
+612
| +1% | +$12K |
|
3359
Comscore
SCOR
$31.6M
| $958K | ﹤0.01% |
41,308
+346
| +0.8% | +$8.02K |
|
3360
Tenaya Therapeutics
TNYA
$212M
| $956K | ﹤0.01% |
475,744
+25,836
| +6% | +$51.9K |
|
|
PHX
3361
DELISTED
PHX Minerals
PHX
| $954K | ﹤0.01% |
245,255
-766
| -0.3% | -$2.98K |
|
3362
Granite Ridge Resources
GRNT
$707M
| $953K | ﹤0.01% |
+105,599
| New | +$953K |
|
3363
Larimar Therapeutics
LRMR
$342M
| $953K | ﹤0.01% |
230,791
+116,901
| +103% | +$483K |
|
3364
P3 Health Partners
PIII
$28.4M
| $953K | ﹤0.01% |
10,362
+121
| +1% | +$11.1K |
|
3365
Palladyne AI
PDYN
$287M
| $949K | ﹤0.01% |
282,014
-84
| -0% | -$283 |
|
3366
Lakeland Industries
LAKE
$131M
| $948K | ﹤0.01% |
71,335
+517
| +0.7% | +$6.87K |
|
3367
TELA Bio
TELA
$62.2M
| $947K | ﹤0.01% |
82,412
+13,792
| +20% | +$158K |
|
|
PACX
3368
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $947K | ﹤0.01% |
93,416
-16,914
| -15% | -$171K |
|
|
ATCO
3369
DELISTED
Atlas Corp.
ATCO
| $942K | ﹤0.01% |
61,457
+723
| +1% | +$11.1K |
|
|
HIMX
3370
Himax Technologies
HIMX
$1.47B
| $941K | ﹤0.01% |
151,558
+75,291
| +99% | +$467K |
|
3371
Eos Energy Enterprises
EOSE
$1.92B
| $940K | ﹤0.01% |
635,635
+82,250
| +15% | +$122K |
|
3372
Lightspeed Commerce
LSPD
$1.58B
| $940K | ﹤0.01% |
65,808
-331,797
| -83% | -$4.74M |
|
3373
Harvard Bioscience
HBIO
$20M
| $939K | ﹤0.01% |
339,021
+2,648
| +0.8% | +$7.33K |
|
|
NAGE
3374
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $938K | ﹤0.01% |
558,849
+5,524
| +1% | +$9.27K |
|
3375
Finward Bancorp
FNWD
$137M
| $931K | ﹤0.01% |
25,719
+2,480
| +11% | +$89.8K |
|